A study looking at breast cancer patients in England compared to those in Norway and Sweden has highlighted the importance of early detection. The three-country comparison reveals that every year almost 1,000 more lives could be saved in England alone.
Ten years ago, molecular biologist Dr Peter H J Riegman set up a unique bio-bank for medical research at the pathology department of Erasmus Medical Centre, Rotterdam, The Netherlands. The Erasmus MC Tissue Bank now holds 30,000 samples from about 15,000 patients. However, when Dr Riegman discusses his bio-bank with international colleagues they do not immediately associate it with a clinic or…
Computer stored data from German health insurers are still inadequate for health services research, according to a study* led by Prof. Wolfgang Greiner, Head of the Healthcare Management department at Bielefeld University, working with his research team in cooperation with the health insurance fund Techniker Krankenkasse.
Researchers have identified 12 new genes associated with Type 2 diabetes (T2D) that look set to improve the understanding of the processes underpinning the condition. The findings could also offer new biological pathways that can be explored as targets for new therapies to tackle T2D.
Initiated in 1999, the Heinz Nixdorf Recall Study involved 4,814 European participants. The results proved, for the first time, the connection between coronary calcifications and the risk of heart attack, according to scientists at the University Hospital in Essen. The finding by no means exhausted the potential inherent in the surveys. Subsidised until 2013, researchers are examining coronary…
A team led by UK-based researchers has found that having diabetes doubles the risk of developing a wide range of blood vessel diseases, including heart attacks and different types of stroke. The consortium, headed by Dr Nadeem Sarwar and Professor John Danesh of the University of Cambridge, analysed data from the individual records on 700,000 people, each of whom was monitored for about a decade…
Trials for a new type of treatment for stroke that could help millions of people at risk of death or disability should commence in 2011. A research team in France has successfully completed laboratory tests of antibodies that protect the brain and reduce the side-effects of current therapy.
When we look at our hands, how do we know they are part of our body? This seems like a strange question because it is something most of us take for granted. Exciting new data from a research group at the Karolinska Institutet in Sweden show that the brain uses a combination of sensory signals from our eyes and limbs to achieve a sense of ‘body ownership’.
The 3-year Translational Research On Combating Antimicrobial Resistance (TROCAR) project, a consortium of 14 European institutes, has completed its first year of molecular study of high-risk antibiotic-resistant bacteria. With expertise ranging from medical microbiology to computational analysis, this network of excellence is on track to identify and target the resistant and multi-resistant…
An increase in survival in metastatic melanoma – the cancer with the most rapidly increasing incidence across the EU – has been shown for the first time in a major international study by researchers from across Europe. The results showed that patients who received a novel monoclonal antibody called ipilimumab lived 34% longer than control patients given gp100 peptide vaccine.
A multiple sclerosis risk sharing scheme, set up by the Department of Health (DoH) in 2002 to ensure that disease-modifying drugs were available on the National Health Service (NHS), has been deemed ‘a costly failure’, according to researchers reporting on www.bmj.com in June. The scheme, they advise, should not be continued.
A new method to produce insulin cheaply has been developed by researchers at the Helmholtz-Centre for Infection Research (HZI) in Braunschweig, in a German-Indo collaboration. The group’s results are published in the open access online research magazine Microbial Cell Factories. The data is freely accessible by anyone and is not subject to patent law.
Type 2 diabetics run an elevated risk of developing cancer, according to the world’s largest study on the combined risk of diabetes and cancer, conducted by scientists at the German Cancer Research Centre (DKFZ). The study focused on 24 types of cancer. The effect is most evident for liver cancer and pancreatic cancer. However, by contrast, diabetics have a significantly lower rate of prostate…
SECARS microscopy, a procedure which is based on quantum effects, with which certain molecules can be monitored virtually in real time, turns out to be a highly sensitive tool for the non-invasive research of the most varied diseases and may supplement the medical diagnosis tools of CT and MRI in the future.
Segmental liver resections and ablative therapies require accurate and precise tumour localization. Because the peritoneal cavity is subject to deformations caused by respiration and topological changes in the surgical site during an intervention, the transfer of MRT and CT tumour data into an intra-operative setting remains a technical challenge.
During conventional electro-cardiology, interference from electromagnetic fields (EMFs) tends to diminish image quality due to cardiac motion. To exclude that interference an acoustic cardiac triggering (ACT) approach, also called MR stethoscope, has been developed to trigger cardiac MRI at 7-Tesla.
Cancer cells producing toxins that destroy tumours – could this be a future treatment for cancer? Researchers at Lund University have achieved good results in tests on both cells and animals. The results have now been presented in the respected scientific journal Cancer Research.
More than 2 million over the world suffer from Multiple sclerosis (MS). It attacks the central nervous system and eventually renders most patients disabled. Although there is currently no cure, a breakthrough finding from a Tel Aviv University scientist and physician may lead to earlier diagnosis, more effective intervention, and perhaps even a cure for the autoimmune disease.
To mark the first European Parkinson’s Action Day on April 12th, the European Parkinson’s Disease Association (EPDA) announced the launch of a major new investigation into the care of people with Parkinson’s across 36 European countries. Parkinson’s disease is the second most common progressive neurodegenerative condition which affects people from all around the world.
A study published online today in the journal Genome Research offers surprising new clues into the genomic complexity of the giant Mimivirus, the largest known virus in the world. Previous studies have shown that unlike most viruses, the Mimivirus has more genes than many bacteria and performs functions that normally occur only in cellular organisms. The results of the most recent study, led by a…
Since June 2009, the focus of research in the European Network for Cell Imaging and Tracking Expertise (ENCITE) has been on finding biomarkers to aid cell transplantation. Funded with €11 million from the European Commission (EC), this major project that runs until 2013, involves 10 countries. Their work is coordinated by the European Institute for Biomedical Imaging Research (EIBIR) network,…
In the current economic environment the introduction of novel imaging approaches and their reimbursement by payers is becoming increasingly difficult. Historically, this denotes a significant change, in that many currently accepted routine tests or interventions were accepted based on common sense, convincing experience or rapid adoption into clinical routine without much scrutiny.
Molecular imaging, the discipline that unites molecular biology and in vivo imaging technologies to assess biological activity in the body, promises to open up ‘…an entire new universe,’ declared Dr Ralph Weissleder, of the Centre for Molecular Imaging Research at Massachusetts General Hospital, USA, in the journal Radiology. That was just one decade ago. And he was right. It has indeed…
At this year’s ECR, new developments will be outlined during the Contrast agents: Experimental and Clinical session. Mark Nicholls spoke with the session moderator Professor Peter Aspelin, Professor in Diagnostic Radiology at the Karolinska Institute, Stockholm, about their potential.
The overall potential benefits of human papillomavirus (HPV) vaccinations or frequent HPV screenings for women over the age of 41 are low, concludes a new study published online February 15 in the Journal of the National Cancer Institute. The study found that the rate of new infections preventable by vaccination declines with age. Furthermore, new infections among women at any age typically do…
